CLEARER SKIN AT 16 WEEKS
In one study, a majority of people taking SOTYKTU saw 75% CLEARER SKIN at Week 16 vs those taking placebo (53% vs 9%).
Skin clearance was also measured in a different way in that study, where half of people taking SOTYKTU saw CLEAR OR ALMOST CLEAR SKIN at Week 16 vs 9% taking placebo.
In the same study, 16% of people saw COMPLETELY CLEAR SKIN at Week 16 compared to 1% taking placebo.
Your results may vary.
SOTYKTU was studied in two large clinical trials:
- 1684 adults were studied
- 841 received SOTYKTU, 422 received Otezla® (apremilast), and 421 received placebo (a pill with no medicine)
- Patients were assessed at 16, 24, and 52 weeks
See photos of real patients treating their moderate to severe plaque psoriasis with SOTYKTU
WHEN TOPICALS AREN'T ENOUGH, ASK FOR SOTYKTU
Your results may vary.
RELIEF FROM A WIDE
RANGE OF SYMPTOMS
In studies, more adults taking SOTYKTU (8% vs 1% for placebo) reported complete relief of psoriasis symptoms (itch, pain, burning, stinging, skin tightness) at Week 16 compared to placebo.
Your results may vary.
RESULTS THAT CAN LAST
In a different study, most people saw 75% clearer skin with SOTYKTU at 1 year. In a continuation of that study, a majority of people saw 75% clearer skin with SOTYKTU at 5 years.*
| * | In a follow-up study at 1 year and thereafter, 485 patients received continuous SOTYKTU through 5 years. Patients and physicians were aware of SOTYKTU treatment, which may have influenced their results. Your results may vary. |
REAL PEOPLE, REAL PHOTOS
See photos of real patients treating their moderate to severe plaque psoriasis with SOTYKTU.
